Innovation

Method to Alter the Receptor Effects of a Drug

University of California System: University of California, Davis - UC Davis
posted on 07/01/2009

A method to alter anesthetic drug specificity for anesthetic-sensitive channels and receptors

Suggested Uses

This invention has application to both clinical anesthetic drug development and to the development of research pharmaceuticals where specific receptor agonists/antagonists are often required.

Advantages

There is currently no known alternative for achieving N-methyl-D-aspartate (NMDA) versus gamma-aminobutyric acid (GABA) receptor specificity for a family of compounds.  This invention may modify any anesthetic or candidate anesthetic receptor-acitivity profile at low-affinity sites by small structural changes.


Innovation Details
 

Detailed Description

A researcher at the University of California, Davis has discovered a way to modify the receptor specificity of anesthetic drugs.  This invention may create new compounds, or modify drugs, that have desirable anesthetic properties.

File Number: 19237 


IP Protection

Copyright: ©2009-2010, The Regents of the University of California

License Online

This innovation currently is not available for online licensing. Please contact Randi Jenkins at University of California System: University of California, Davis - UC Davis for more information.

request more info
People

Case Manager:

Icon_avatar Randi Jenkins

Innovations (46)

Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

4,069 members 12,307 innovations 109 organizations

Browse

Patrick Jones, Ph.D. Director, Technology Transfer - University of Arizona

"The iBridge Network nicely embodies the ideals of a well-designed, non-profit mechanism for aggregating, searching, and disseminating innovations from multiple research institutions."  read more...